Biomarkers and surrogate endpoints in renal transplantation:: Present status and considerations for clinical trial design

被引：54

作者：

Lachenbruch, PA

Rosenberg, AS ^{[1
]}

Bonvini, E

Cavaillé-Coll, MW

Colvin, RB

机构：

[1] US FDA, Ctr Biol Evaluat & Res, Off Therapeut Res & Review, Div Therapeut Prot, Bethesda, MD 20892 USA

[2] US FDA, Ctr Biol Evaluat & Res, Off Therapeut Res & Review, Div Monoclonal Antibodies, Bethesda, MD 20892 USA

[3] US FDA, Ctr Biol Evaluat & Res, Off Biostat & Epidemiol, Div Biostat, Bethesda, MD 20892 USA

[4] US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Div Special Pathogen & Immunol Drug Prod, Rockville, MD USA

[5] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA

[6] Harvard Univ, Sch Med, Boston, MA 02114 USA

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2004年 / 4卷 / 04期

关键词：

allograft rejection; predictive variables; surrogate endpoints;

D O I：

10.1111/j.1600-6143.2004.00386.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Of major importance in clinical trials is the ability to predict individual patient outcome or endpoints using biomarkers, also known as variables or predictors, in as safe, efficient, and accurate a manner as possible. This review addresses the concepts and possible strategies for use of predictor and surrogate biomarkers in the design of clinical trials in renal transplantation. The statistical concepts apply equally well to other organ grafts.

引用

收藏

页码：451 / 457

页数：7

相关论文

共 31 条

[1] Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology [J].

Akalin, E ;

Hendrix, RC ;

Polavarapu, RG ;

Pearson, TC ;

Neylan, JF ;

Larsen, CP ;

Lakkis, FG .

TRANSPLANTATION, 2001, 72 (05) :948-953

[2] An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome [J].

Bates, WD ;

Davies, DR ;

Welsh, K ;

Gray, DWR ;

Fuggle, SV ;

Morris, PJ .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (10) :2364-2369

[3]

Colvin RB, 1997, J AM SOC NEPHROL, V8, P1930

[4] Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection [J].

Dugré, FJ ;

Gaudreau, S ;

Belles-Isles, M ;

Houde, I ;

Roy, R .

TRANSPLANTATION, 2000, 70 (07) :1074-1080

[5] High transforming growth factor-β and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection [J].

Eikmans, M ;

Sijpkens, YWJ ;

Baelde, HJ ;

De Heer, E ;

Paul, LC ;

Bruijn, JA .

TRANSPLANTATION, 2002, 73 (04) :573-579

[6] Glomerular filtration rate as a putative 'surrogate end-point' for renal transplant clinical trials in children [J].

Filler, G ;

Browne, R ;

Seikaly, MG .

PEDIATRIC TRANSPLANTATION, 2003, 7 (01) :18-24

[7]

Fisher L.D., 1993, BIOSTATISTICS METHOD

[8] International variation in histologic grading is large, and persistent feedback does not improve reproducibility [J].

Furness, PN ;

Taub, N ;

Assmann, KJM ;

Banfi, G ;

Cosyns, JP ;

Dorman, AM ;

Hill, CM ;

Kapper, SK ;

Waldherr, R ;

Laurinavicius, A ;

Marcussen, N ;

Martins, AP ;

Nogueira, M ;

Regele, H ;

Seron, D ;

Carrera, M ;

Sund, S ;

Taskinen, EI ;

Paavonen, T ;

Tihomirova, T ;

Rosenthal, R .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (06) :805-810

[9] Correlation of histology to clinical rejection reversal: A Thymoglobulin Multicenter Trial report [J].

Gaber, LW ;

Moore, LW ;

Gaber, AO ;

Tesi, RJ ;

Meyer, J ;

Schroeder, TJ .

KIDNEY INTERNATIONAL, 1999, 55 (06) :2415-2422

[10] Computerized image analysis of sirius red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function [J].

Grimm, PC ;

Nickerson, P ;

Gough, J ;

McKenna, R ;

Stern, E ;

Jeffery, J ;

Rush, DN .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (06) :1662-1668

← 1 2 3 4 →